TAFLON 25MG FILM COATED TABLETS

Manufacturer
SHIJIAZHUANG LONZEAL PHARMACEUTICALS CO., LTD(CHINA)

Registraction Number
MAL24106013AZ

Content:
TAFLON 25mg Film Coated Tablets contain Tenofovir Alafenamide Fumarate, equivalent to 25 mg. The tablets are yellow, round-shaped, and film-coated with white or off-white cores1.
Indications:
TAFLON is indicated for the treatment of:

• Chronic Hepatitis B: In adults and adolescents aged 12 years and older, weighing at least 35 kg. Hepatitis B is a liver infection caused by the hepatitis B virus2.

• Adults and Adolescents: One tablet once daily.
• Treatment Discontinuation: In HBeAg-positive patients without cirrhosis, treatment should be administered for at least 6-12 months after HBe seroconversion. In HBeAg-negative patients without cirrhosis, treatment should be continued until HBs seroconversion or loss of efficacy.